SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meike Kasten, Eva-Juliane Vollstedt, Christine Klein, Frühsymptome und neuropsychiatrische Symptome bei der Parkinson-Erkrankung, Zeitschrift für Neuropsychologie, 2014, 25, 1, 31

    CrossRef

  2. 2
    Susan H Fox, Pimavanserin as treatment for Parkinson's disease psychosis, The Lancet, 2014, 383, 9916, 494

    CrossRef

  3. 3
    T. Lebouvier, J. Delrieu, S. Evain, A. Pallardy, A. Sauvaget, F. Letournel, R. Chevrier, M. Lepetit, M. Vercelletto, C. Boutoleau-Bretonnière, P. Derkinderen, Démences : où sont les corps de Lewy ?, Revue Neurologique, 2013, 169, 11, 844

    CrossRef

  4. 4
    Tiffini Voss, Daun Bahr, Jeffrey Cummings, Roger Mills, Bernard Ravina, Hilde Williams, Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis, Parkinsonism & Related Disorders, 2013, 19, 3, 295

    CrossRef

  5. 5
    Abdul Qayyum Rana, Ishraq Siddiqui, Masood Zangeneh, Abdul Fattah, Naeem Awan, Muhammad Saad Yousuf, Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients, Psychiatry and Clinical Neurosciences, 2013, 67, 7
  6. 6
    Thien Lim, Kelvin Chou, Hubert Fernandez, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  7. 7
    Thien Thien Lim, Kelvin L. Chou, Hubert H. Fernandez, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  8. 8
    Pablo Martinez-Martin, Belen Frades-Payo, Luis Agüera-Ortiz, Angel Ayuga-Martinez, A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease: first psychometric approach, Journal of Neurology, 2012, 259, 11, 2299

    CrossRef

  9. 9
    Kurt A. Jellinger, Cerebral correlates of psychotic syndromes in neurodegenerative diseases, Journal of Cellular and Molecular Medicine, 2012, 16, 5
  10. 10
    Michele Poletti, Giulio Perugi, Chiara Logi, Anna Romano, Paolo Del Dotto, Roberto Ceravolo, Giuseppe Rossi, Pasquale Pepe, Liliana Dell'Osso, Ubaldo Bonuccelli, Dopamine agonists and delusional jealousy in Parkinson's disease: A cross-sectional prevalence study, Movement Disorders, 2012, 27, 13
  11. 11
    Barbara S Connolly, Susan H Fox, Drug treatments for the neuropsychiatric complications of Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1439

    CrossRef

  12. 12
    James M. Shine, Glenda H. Halliday, Mayra Carlos, Sharon L. Naismith, Simon J.G. Lewis, Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm, Movement Disorders, 2012, 27, 4
  13. 13
    Joel Mack, Peter Rabins, Karen Anderson, Susanne Goldstein, Stephen Grill, Elaina S. Hirsch, Susan Lehmann, John T. Little, Russell L. Margolis, Justin Palanci, Gregory Pontone, Howard Weiss, James R. Williams, Laura Marsh, Prevalence of Psychotic Symptoms in a Community-Based Parkinson Disease Sample, The American Journal of Geriatric Psychiatry, 2012, 20, 2, 123

    CrossRef

  14. 14
    Paulo Bugalho, Joaquim Alves Silva, Inês Cargaleiro, Madalena Serra, Bernardo Neto, Psychiatric symptoms screening in the early stages of Parkinson’s disease, Journal of Neurology, 2012, 259, 1, 124

    CrossRef

  15. 15
    Sergio E. Starkstein, Simone Brockman, Bradleigh D. Hayhow, Psychiatric syndromes in Parkinsonʼs disease, Current Opinion in Psychiatry, 2012, 25, 6, 468

    CrossRef

  16. 16
    I. Cargaleiro, M. Serra, J. Alves da Silva, B. Neto, M. Gonçalves-Pereira, P. Bugalho, Psychosis Assessment in Early-Stage Parkinson’s Disease: Comparing Parkinson’s Psychosis Questionnaire with the Brief Psychiatric Rating Scale in a Portuguese Sample, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  17. 17
    Angela H. Lee, Daniel Weintraub, Psychosis in Parkinson's disease without dementia: Common and comorbid with other non-motor symptoms, Movement Disorders, 2012, 27, 7
  18. 18
    Sergio E. Starkstein, The Riddle of Psychiatric Disorders in Parkinson Disease: From Phenomenology to Treatment, The American Journal of Geriatric Psychiatry, 2012, 20, 2, 99

    CrossRef

  19. 19
    Jennifer G Goldman, Christina L Vaughan, Christopher G Goetz, An update expert opinion on management and research strategies in Parkinson's disease psychosis, Expert Opinion on Pharmacotherapy, 2011, 12, 13, 2009

    CrossRef

  20. 20
    Dag Aarsland, Uwe Ehrt, Irena Rektorova, Cognitive and psychiatric disturbances in Parkinson’s disease, Aging Health, 2011, 7, 1, 123

    CrossRef

  21. 21
    Pablo Martinez-Martin, Martine Jeukens-Visser, Kelly E. Lyons, C. Rodriguez-Blazquez, Caroline Selai, Andrew Siderowf, Mickie Welsh, Werner Poewe, Oliver Rascol, Cristina Sampaio, Glenn T. Stebbins, Christopher G. Goetz, Anette Schrag, Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2011, 26, 13
  22. 22
    Joseph H Friedman, Managing psychosis in Parkinson’s disease, Neurodegenerative Disease Management, 2011, 1, 3, 217

    CrossRef

  23. 23
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  24. 24
    Angelo Antonini, Pablo Martinez-Martin, Ray K. Chaudhuri, Marcelo Merello, Robert Hauser, Regina Katzenschlager, Per Odin, Mark Stacy, Fabrizio Stocchi, Werner Poewe, Oliver Rascol, Cristina Sampaio, Anette Schrag, Glenn T. Stebbins, Christopher G. Goetz, Wearing-off scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2011, 26, 12
  25. 25
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  26. 26
    G. Fénelon, La maladie de Parkinson, 2011,

    CrossRef

  27. 27
    Javier Virués-Ortega, Carmen Rodríguez-Blázquez, Federico Micheli, Francisco Javier Carod-Artal, Marcos Serrano-Dueñas, Pablo Martínez-Martín, Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages, Movement Disorders, 2010, 25, 10
  28. 28
    Gilles Fénelon, Guido Alves, Epidemiology of psychosis in Parkinson's disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 12

    CrossRef

  29. 29
    Joseph H. Friedman, Guido Alves, Peter Hagell, Johan Marinus, Laura Marsh, Pablo Martinez-Martin, Christopher G. Goetz, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn Stebbins, Anette Schrag, Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease, Movement Disorders, 2010, 25, 7
  30. 30
    C.G. Goetz, Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : une nouvelle échelle pour l’évaluation de la maladie de Parkinson, Revue Neurologique, 2010, 166, 1, 1

    CrossRef

  31. 31
    Joseph H. Friedman, Parkinson’s disease psychosis 2010: A review article, Parkinsonism & Related Disorders, 2010, 16, 9, 553

    CrossRef

  32. You have free access to this content32
    Tiffini S. Voss, Alicia F.D. Brocht, Bernard Ravina, Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis, Movement Disorders, 2010, 25, 1
  33. 33
    Herbert Y Meltzer, Roger Mills, Stephen Revell, Hilde Williams, Ann Johnson, Daun Bahr, Joseph H Friedman, Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis, Neuropsychopharmacology, 2010, 35, 4, 881

    CrossRef

  34. 34
    Birgit Högl, Isabelle Arnulf, Cynthia Comella, Joaquim Ferreira, Alex Iranzo, Barbara Tilley, Claudia Trenkwalder, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 16
  35. 35
    Marc R. Bothe, Ingo Uttner, Markus Otto, Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure, Journal of Neural Transmission, 2010, 117, 3, 353

    CrossRef

  36. 36
    Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 9
  37. 37
    Gilles Fénelon, Thierry Soulas, Franck Zenasni, Laurent Cleret de Langavant, The changing face of Parkinson's disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria, Movement Disorders, 2010, 25, 6
  38. 38
    Rachel Debs, Valérie Cochen De Cock, Laurence Nègre-Pagès, Marina Aristin, Anna Senard, Olivier Rascol, Thought disorders among non-demented outpatients with Parkinson’s disease: prevalence and associated factors, Journal of Neural Transmission, 2010, 117, 10, 1183

    CrossRef

  39. 39
    L.B. Zahodne, H.H. Fernandez, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  40. 40
    J.G. Goldman, B.A. Bernard, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  41. 41
    G. Fénelon, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  42. 42
    Josè Martin Rabey, Hallucinations and psychosis in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S105

    CrossRef

  43. 43
    Nico J. Diederich, Gilles Fénelon, Glenn Stebbins, Christopher G. Goetz, Hallucinations in Parkinson disease, Nature Reviews Neurology, 2009, 5, 6, 331

    CrossRef

  44. 44
    Dag Aarsland, Laura Marsh, Anette Schrag, Neuropsychiatric symptoms in Parkinson's disease, Movement Disorders, 2009, 24, 15
  45. 45
    HUBERT H. FERNANDEZ, MICHAEL S. OKUN, RAMON L. RODRIGUEZ, IRENE A. MALATY, JANET ROMRELL, ANQI SUN, SAMUEL S. WU, SANDEEP PILLARISETTY, ANAND NYATHAPPA, STEPHAN EISENSCHENK, QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY, International Journal of Neuroscience, 2009, 119, 12, 2196

    CrossRef

  46. 46
    Christopher G. Goetz, Scales to evaluate psychosis in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S38

    CrossRef

  47. 47
    Christopher G. Goetz, Wenqing Fan, Sue Leurgans, Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening, Movement Disorders, 2008, 23, 11
  48. 48
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Daniel Weintraub, Christina Sampaio, Werner Poewe, Oliver Rascol, Glenn T. Stebbins, Christopher G. Goetz, Anxiety rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 14
  49. 49
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Daniel Weintraub, Cristina Sampaio, Werner Poewe, Oliver Rascol, Glenn T. Stebbins, Christopher G. Goetz, Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 14
  50. 50
    Jennifer G. Goldman, Christopher G. Goetz, Melanie Brandabur, Michelle Sanfilippo, Glenn T. Stebbins, Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies, Movement Disorders, 2008, 23, 15
  51. You have free access to this content51
    Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B. Stern, Richard Dodel, Bruno Dubois, Robert Holloway, Joseph Jankovic, Jaime Kulisevsky, Anthony E. Lang, Andrew Lees, Sue Leurgans, Peter A. LeWitt, David Nyenhuis, C. Warren Olanow, Olivier Rascol, Anette Schrag, Jeanne A. Teresi, Jacobus J. van Hilten, Nancy LaPelle, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results, Movement Disorders, 2008, 23, 15
  52. 52
    Laura B Zahodne, Hubert H Fernandez, Pathophysiology and Treatment of Psychosis in Parkinson’s Disease, Drugs & Aging, 2008, 25, 8, 665

    CrossRef

  53. 53
    Frank Schneider, Astrid Althaus, Volker Backes, Richard Dodel, Psychiatric symptoms in Parkinson’s disease, European Archives of Psychiatry and Clinical Neuroscience, 2008, 258, S5, 55

    CrossRef

  54. 54
    Christopher G. Goetz, Cristina Sampaio, Assessment of Non-Motor Features of Parkinson's Disease: Scales and Rating Tools,
  55. 55
    Karl Kieburtz, Clinical Trial Measures of the Non-Motor Features of Parkinson's Disease,
  56. 56
    Joseph H. Friedman, Psychosis in Parkinson's Disease,